TYBR Health
It develops the B3 GEL® System, a medical technology platform for healthcare providers, and is using Series A capital to broaden patient access.
Overview
TYBR Health builds the B3 GEL® System, a healthcare technology product positioned for clinical use and broader patient access. The company targets healthcare providers and care settings that can adopt the system as part of patient treatment workflows. The company’s key disclosed differentiator is its proprietary B3 GEL® System. TYBR Health raised a $30 million Series A in July 2026, bringing total disclosed funding to $30 million, with the round intended to expand access to the product.
Funding History
TYBR Health Announces $30 Million Series A Financing to Expand Access to the B3 GEL® System
Frequently Asked Questions
- How much has TYBR Health raised in total?
- TYBR Health has raised a total of $30M across 1 funding round.
- What does TYBR Health do?
- TYBR Health builds the B3 GEL® System, a healthcare technology product positioned for clinical use and broader patient access. The company targets healthcare providers and care settings that can adopt the system as part of patient treatment workflows. The company’s key disclosed differentiator is its proprietary B3 GEL® System. TYBR Health raised a $30 million Series A in July 2026, bringing total disclosed funding to $30 million, with the round intended to expand access to the product.
- Where is TYBR Health headquartered?
- TYBR Health is headquartered in Houston, United States.
Related Insights
A comprehensive analysis of Sage's funding history, investors, competitive position, and growth trajectory in the AI Healthcare space.
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $35.9 billion raised across 95 deals, with 15 mega-rounds capturing 85.5% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.